These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


673 related items for PubMed ID: 14979885

  • 21. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
    Miner JR, Smith SW, Moore J, Biros M.
    Am J Emerg Med; 2007 Jan; 25(1):60-4. PubMed ID: 17157685
    [Abstract] [Full Text] [Related]

  • 22. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 23. The Sinus, Allergy and Migraine Study (SAMS).
    Eross E, Dodick D, Eross M.
    Headache; 2007 Feb; 47(2):213-24. PubMed ID: 17300361
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS.
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [Abstract] [Full Text] [Related]

  • 26. Intravenous valproate sodium in the treatment of daily headache.
    Schwartz TH, Karpitskiy VV, Sohn RS.
    Headache; 2002 Jun; 42(6):519-22. PubMed ID: 12167141
    [Abstract] [Full Text] [Related]

  • 27. Treatment of sinus headache as migraine: the diagnostic utility of triptans.
    Kari E, DelGaudio JM.
    Laryngoscope; 2008 Dec; 118(12):2235-9. PubMed ID: 18948830
    [Abstract] [Full Text] [Related]

  • 28. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J, Cady R, Singer R, Peters K, Webster C, Kori S, Byrd S.
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [Abstract] [Full Text] [Related]

  • 29. Migraine pain location: a tertiary care study of 1283 migraineurs.
    Kelman L.
    Headache; 2005 Sep; 45(8):1038-47. PubMed ID: 16109118
    [Abstract] [Full Text] [Related]

  • 30. Treating early versus treating mild: timing of migraine prescription medications among patients with diagnosed migraine.
    Foley KA, Cady R, Martin V, Adelman J, Diamond M, Bell CF, Dayno JM, Hu XH.
    Headache; 2005 May; 45(5):538-45. PubMed ID: 15953272
    [Abstract] [Full Text] [Related]

  • 31. Migraine changes with age: IMPACT on migraine classification.
    Kelman L.
    Headache; 2006 May; 46(7):1161-71. PubMed ID: 16866720
    [Abstract] [Full Text] [Related]

  • 32. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.
    Young W, Shaw J, Bloom M, Gebeline-Myers C.
    Headache; 2008 May; 48(10):1490-8. PubMed ID: 19076647
    [Abstract] [Full Text] [Related]

  • 33. Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study.
    Matharu MS, Levy MJ, Meeran K, Goadsby PJ.
    Ann Neurol; 2004 Oct; 56(4):488-94. PubMed ID: 15455406
    [Abstract] [Full Text] [Related]

  • 34. Mexiletine for refractory chronic daily headache: a report of nine cases.
    Marmura MJ, Passero FC, Young WB.
    Headache; 2008 Oct; 48(10):1506-10. PubMed ID: 18793209
    [Abstract] [Full Text] [Related]

  • 35. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache.
    Edwards KR, Norton J, Behnke M.
    Headache; 2001 Oct; 41(10):976-80. PubMed ID: 11903525
    [Abstract] [Full Text] [Related]

  • 36. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
    Aurora SK, Rozen TD, Kori SH, Shrewsbury SB.
    Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249
    [Abstract] [Full Text] [Related]

  • 37. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF, Foley KA, Barlas S, Solomon G, Hu XH.
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [Abstract] [Full Text] [Related]

  • 38. Women's issues of migraine in tertiary care.
    Kelman L.
    Headache; 2004 Jan; 44(1):2-7. PubMed ID: 14979877
    [Abstract] [Full Text] [Related]

  • 39. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ.
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [Abstract] [Full Text] [Related]

  • 40. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study.
    Honkaniemi J, Liimatainen S, Rainesalo S, Sulavuori S.
    Headache; 2006 May; 46(5):781-7. PubMed ID: 16643581
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 34.